Literature DB >> 9346938

Oncogenic c-Ki-ras but not oncogenic c-Ha-ras up-regulates CEA expression and disrupts basolateral polarity in colon epithelial cells.

Z Yan1, X Deng, M Chen, Y Xu, M Ahram, B F Sloane, E Friedman.   

Abstract

Colon carcinomas commonly contain mutations in Ki-ras4B, but very rarely in Ha-ras, suggesting that different Ras isoforms may have distinct functions in colon epithelial cell biology. In an earlier study we had demonstrated that oncogenic Ki-ras4BVal-12, but not oncogenic Ha-rasVal-12, blocks the apicobasal polarization of colon epithelial cells by preventing normal glycosylation of the integrin beta1 chain of the collagen receptor. As a result, only the Ki-ras mutated cells exhibited altered cell to substratum attachment, whereas mutation of either Ras isoform activated mitogen-activated protein kinases. We have now asked whether intercellular adhesion proteins implicated in establishing basolateral polarity in colon epithelial cells are modulated by oncogenic Ki-Ras4BVal-12 proteins but not oncogenic Ha-RasVal-12 proteins. The embryonic adhesion protein carcinoembryonic antigen (CEA) was up-regulated on the mRNA and protein levels in each of three stable Ki-rasVal-12 transfectant lines but in none of three stable Ha-rasVal-12 transfectant lines. The elevated protein levels of CEA in Ki-ras4BVal-12 transfectant cells were decreased by blocking expression of Ki-ras4BVal-12 with antisense oligonucleotides. N-cadherin levels were decreased in only the Ki-ras transfectants, whereas E-cadherin levels were unchanged. Immunohistochemical analysis demonstrated that Ki-ras4BVal-12 transfectant cells did not polarize into cells with discrete apical and basal regions and so could not restrict expression of CEA to the apical region. These unpolarized cells displayed elevated levels of CEA all along their surface membrane where CEA mediated random, multilayered associations of tumor cells. This aggregation was both calcium-independent and blocked by Fab' fragments of anti-CEA monoclonal antibody col-1. Trafficking of the lysosomal cysteine protease cathepsin B may also be altered when cell polarity cannot be established. Ki-ras4BVal-12 transfectant cells expressed 2-fold elevated protein levels of the lysosomal cysteine protease cathepsin B but did not up-regulate cathepsin B mRNA expression. One function of oncogenic c-Ki-Ras proteins in colon cancer progression may be to up-regulate CEA and thus to prevent the lateral adhesion of adjacent colon epithelial cells that normally form a monolayer in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9346938     DOI: 10.1074/jbc.272.44.27902

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Defect in CEACAM family member expression in Crohn's disease IECs is regulated by the transcription factor SOX9.

Authors:  Giulia Roda; Stephanie Dahan; Laura Mezzanotte; Alessandra Caponi; Franziska Roth-Walter; David Pinn; Lloyd Mayer
Journal:  Inflamm Bowel Dis       Date:  2009-07-27       Impact factor: 5.325

2.  Cathepsin B: Basis Sequence: Mouse.

Authors:  Dora Cavallo-Medved; Kamiar Moin; Bonnie Sloane
Journal:  AFCS Nat Mol Pages       Date:  2011-04-10

Review 3.  Cathepsin B: multiple roles in cancer.

Authors:  Neha Aggarwal; Bonnie F Sloane
Journal:  Proteomics Clin Appl       Date:  2014-03-26       Impact factor: 3.494

4.  Label-free quantitative proteomics and N-glycoproteomics analysis of KRAS-activated human bronchial epithelial cells.

Authors:  Putty-Reddy Sudhir; Chein-Hung Chen; Madireddy Pavana Kumari; Mei-Jung Wang; Chih-Chiang Tsou; Ting-Yi Sung; Jeou-Yuan Chen; Chung-Hsuan Chen
Journal:  Mol Cell Proteomics       Date:  2012-07-03       Impact factor: 5.911

5.  Functional specificity of ras isoforms: so similar but so different.

Authors:  Esther Castellano; Eugenio Santos
Journal:  Genes Cancer       Date:  2011-03

6.  Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation.

Authors:  Christian Ilantzis; Luisa DeMarte; Robert A Screaton; Clifford P Stanners
Journal:  Neoplasia       Date:  2002 Mar-Apr       Impact factor: 5.715

Review 7.  Clinical relevance of KRAS in human cancers.

Authors:  Sylwia Jancík; Jirí Drábek; Danuta Radzioch; Marián Hajdúch
Journal:  J Biomed Biotechnol       Date:  2010-06-07

8.  Mutant K-ras regulates cathepsin B localization on the surface of human colorectal carcinoma cells.

Authors:  Dora Cavallo-Medved; Julie Dosescu; Bruce E Linebaugh; Mansoureh Sameni; Debbie Rudy; Bonnie F Sloane
Journal:  Neoplasia       Date:  2003 Nov-Dec       Impact factor: 5.715

9.  Mirk regulates the exit of colon cancer cells from quiescence.

Authors:  Kideok Jin; Daina Z Ewton; Sunju Park; Jing Hu; Eileen Friedman
Journal:  J Biol Chem       Date:  2009-06-19       Impact factor: 5.157

10.  Characterizing CEACAM5 interaction with CD8α and CD1d in intestinal homeostasis.

Authors:  G Roda; X Jianyu; M S Park; L DeMarte; Z Hovhannisyan; R Couri; C P Stanners; G Yeretssian; L Mayer
Journal:  Mucosal Immunol       Date:  2013-10-09       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.